| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Graduate Program in Microbiology and Immunology and 2 Department of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; 3 Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts; and 4 Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Certain lymphomas in AIDS patients, such as primary effusion lymphoma (PEL), are closely associated with the lymphotropic 
herpes virus Kaposi’s sarcoma-associated herpes virus (KSHV), also called human herpesvirus 8. The virus is thought to be essential for tumorigenesis, yet systems to investigate PEL in vivo are rare. Here we describe PEL tumorigenesis in a new xenograft model. Embedded in Matrigel, PEL cells formed rapid, well-organized, and angiogenic tumors after s.c. implantation of C.B.17 SCID mice. Without Matrigel we did not observe comparable tumors, which implies that extracellular support and/or signaling aids PEL. All of the tumors maintained the KSHV genome, and the KSHV latent protein LANA/orf73 was uniformly expressed. However, the expression profile for key lytic mRNAs, as well as LANA-2/vIRF3, differed between tissue culture and sites of implantation. We did not observe a net effect of ganciclovir on PEL growth in culture or as xenograft. These findings underscore the importance of the microenvironment for PEL tumorigenesis and simplify the preclinical evaluation of potential anticancer agents.
This article has been cited by other articles:
|
|
 |
|
  A. J. O'Hara, L. Wang, B. J. Dezube, W. J. Harrington Jr, B. Damania, and D. P. Dittmer Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma Blood, June 4, 2009; 113(23): 5938 - 5941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Calabro, P. Gasperini, I. M. Di Gangi, S. Indraccolo, M. Barbierato, A. Amadori, and L. Chieco-Bianchi Antineoplastic activity of lentiviral vectors expressing interferon-{alpha} in a preclinical model of primary effusion lymphoma Blood, May 7, 2009; 113(19): 4525 - 4533. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. O'Hara, W. Vahrson, and D. P. Dittmer Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma Blood, February 15, 2008; 111(4): 2347 - 2353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Davis, K. E. Singer, I. P. Reynolds, M. Haque, and R. Yarchoan Hypoxia Enhances the Phosphorylation and Cytotoxicity of Ganciclovir and Zidovudine in Kaposi's Sarcoma-Associated Herpesvirus Infected Cells Cancer Res., July 15, 2007; 67(14): 7003 - 7010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Sin, D. Roy, L. Wang, M. R. Staudt, F. D. Fakhari, D. D. Patel, D. Henry, W. J. Harrington Jr, B. A. Damania, and D. P. Dittmer Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling Blood, March 1, 2007; 109(5): 2165 - 2173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Petre, S.-H. Sin, and D. P. Dittmer Functional p53 Signaling in Kaposi's Sarcoma-Associated Herpesvirus Lymphomas: Implications for Therapy J. Virol., February 15, 2007; 81(4): 1912 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-Q. An, H. M. Folarin, N. Compitello, J. Roth, S. L. Gerson, K. R. McCrae, F. D. Fakhari, D. P. Dittmer, and R. Renne Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In Vivo. J. Virol., May 1, 2006; 80(10): 4833 - 4846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, D. P. Dittmer, C. C. Tomlinson, F. D. Fakhari, and B. Damania Immortalization of Primary Endothelial Cells by the K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus. Cancer Res., April 1, 2006; 66(7): 3658 - 3666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chang, D. P. Dittmer, S.-Y. Chul, Y. Hong, and J. U. Jung Role of Notch Signal Transduction in Kaposi's Sarcoma-Associated Herpesvirus Gene Expression J. Virol., November 15, 2005; 79(22): 14371 - 14382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Godfrey, J. Anderson, A. Papanastasiou, Y. Takeuchi, and C. Boshoff Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA Blood, March 15, 2005; 105(6): 2510 - 2518. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
